 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Neumega®
                                 oprelvekin is an approved drug (FDA (1997)) Compound class: 
                                                            Peptide
                                 
                                    
                                        Comment: This is a non-glycosylated, recombinant form of human IL-11 produced in E.coli.  Oprelvekin is one amino acid shorter than the endogenous peptide, lacking the amino-terminal proline residue.
                                    
                                 | 
| Classification  | |
| Compound class | Peptide | 
| Approved drug? | Yes. US FDA (1997) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 7558 | oprelvekin | 
| Synonyms  | 
| Neumega® | 
| Database Links  | |
| ChEMBL Ligand | CHEMBL1201573 | 
| DrugBank Ligand | DB00038 | 
| GtoPdb PubChem SID | 178103550 | 
| Search PubMed clinical trials | oprelvekin | 
| Search PubMed titles | oprelvekin | 
| Search PubMed titles/abstracts | oprelvekin | 
| Wikipedia | Oprelvekin |